Notably, increased immune recognition and resultant cytolysis of tumor cells by T cells and NK cells has been achieved through HDAC inhibitors and DNA hypomethylating agents (e.g., decitabine) (44, 46, 104, 185). This evidence concerns the gene HDAC9 and neoplasm.